At least 50 patients go for CAR-T treatment to China, which has more than 200 outfits working in this area, say industry insiders. In comparison, India has three players, and only one of themImmunoACT has a CAR-T product available commercially.
But things could change.
Rahul Purwar, founder and chairman of ImmunoACT, says not many would have gone to China for treatment since the IIT Bombay spinoff, backed by Hyderabad-based Laurus Labs, started commercially offering CAR-T therapy (NexCAR19) in India last November.
"We are offering the treatment at $50,000 and their cost is around $200,000. So, India obviously has a major edge here," he says.
In the US, this costs $800,000$900,000 per patient, including pre and post-infusion care.
The immune system is the body's natural defence against infections and old or abnormal cells, including those that make up cancer. In CAR-T treatment, chimeric antigen receptor T cells (CAR-T) are genetically engineered to produce an artificial T cell receptor for use in immunotherapy.
Traditionally, CAR-T is delivered through the autologous route, which involves extracting the patient's blood, genetically re-engineering the cells, and infusing it back into the patient. The process takes three weeks or sovein to vein.
ImmunoACT's CAR-T product was approved by the Indian drug regulator last October for B-cell malignancies.
"If any country can bring the cost of this therapy down, it is India, as we have talented manpower," says Esha Kaul, Director, HaematoOncology, Bone Marrow Transplant, Max Super Speciality Hospital, Vaishali, on the outskirts of Delhi.
Purwar says around 2,500 patients are in the queue for receiving CAR-T treatment at ImmunoACT, which is increasing its capacity. In 2024-25, it will be able to process 300-500 patients, and by March 2025 it would have a capacity to process 2,000 patients a year.
Next frontier
هذه القصة مأخوذة من طبعة March 30, 2024 من Business Standard.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 8500 مجلة وصحيفة.
بالفعل مشترك ? تسجيل الدخول
هذه القصة مأخوذة من طبعة March 30, 2024 من Business Standard.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 8500 مجلة وصحيفة.
بالفعل مشترك? تسجيل الدخول
Indian-American Bruhat Soma wins National Spelling Bee
Bruhat Soma, a 12-year-old IndianAmerican seventh-grade student from Florida, has won the Scripps National Spelling Bee after he spelt 29 words correctly in the tiebreaker, maintaining the dominance of the children from the small ethnic community in the prestigious competition.
Charging ahead
Chandra tells SOHINI DAS why he is determined to focus on net carbon zero rather than lose track to distractions
WIND BENEATH INDIGO'S WINGS
Turboprop planes have helped IndiGo rule the regional aviation network for the last five years. And there might be more coming
S&P may raise ratings if fiscal glide path stays
Says will closely observe India's policy for 2 yrs
Georgia reaches out to India to begin FTA talks
Georgia, the Southern Caucasus country, has reached out to India to start negotiations for a free-trade agreement (FTA), said a person aware of the matter.
States hit 84% of FY24 capex target
The provisional accounts of 25 states for the financial year 2023-2024 (FY24) showed they achieved 84 per cent of the budgeted capital expenditure, with four states Uttar Pradesh, Telangana, Bihar, and Sikkimspending 100 per cent or more than the targeted amount, according to data compiled by the Comptroller and Auditor General of India (CAG).
Tata Capital eyes 35% rise in FY25 retail loans
Tata Capital expects its retail loan portfolio to grow 35 per cent in the financial year 202425 (FY25) - slightly slower than the previous year due to a high base effect and a slowdown in personal loans due to regulatory action, said a senior executive of the company.
NIFTY SEES RARE DECLINE AFTER 3 MONTHS OF GAIN
The benchmark Nifty ended May with a decline of 0.3 per cent, snapping its three-month winning streak, amid heightened volatility.
After rally, NMDC stock to price in positives
NMDC, the country's largest ironore miner, posted a consolidated revenue in the January-March quarter of FY24.
Some economic sectors trading at ‘euphoric valuations
The Indian stock market is a mix of optimism about the economy and \"euphoria\" that is not linked to fundamentals, said analysts at Kotak Securities ahead of election results on Tuesday.